← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Commercial Officer Mark Neumann sold $796K of Intra-Cellular Therapies, Inc.

Sold$796,367
$67.15Price
11,860Shares
−29%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Fri, Feb 2. Filed Mon, Feb 5, 1:07 PM ET, during the session. Not investment advice.